MRAI
Price:
$1.23
Market Cap:
$16.91M
Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services. It also develops artificial intelligence and healthcare technology that enables the analysis of data to predict and prevent events related to diagnostic errors, hospital visits, and administrative issues. The company was incorporated in 2021 and is headquartered in New York, New York.[Read more]
Industry
Medical - Healthcare Plans
IPO Date
2021-10-27
Stock Exchange
NASDAQ
Ticker
MRAI
According to Marpai, Inc.’s latest financial reports and current stock price. The company's current ROE is 127.94%. This represents a change of 290.49% compared to the average of 32.76% of the last 4 quarters.
The mean historical ROE of Marpai, Inc. over the last ten years is 9.30%. The current 127.94% ROE has changed 1.28% with respect to the historical average. Over the past ten years (40 quarters), MRAI's ROE was at its highest in in the March 2023 quarter at 502.84%. The ROE was at its lowest in in the December 2022 quarter at -138.31%.
Average
9.30%
Median
126.27%
Minimum
-431.51%
Maximum
213.95%
Discovering the peaks and valleys of Marpai, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 701.99%
Maximum Annual ROE = 213.95%
Minimum Annual Increase = -149.58%
Minimum Annual ROE = -431.51%
Year | ROE | Change |
---|---|---|
2023 | 213.95% | -149.58% |
2022 | -431.51% | 701.99% |
2021 | -53.81% | -142.61% |
2020 | 126.27% | -34.10% |
The current ROE of Marpai, Inc. (MRAI) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-90.46%
5-year avg
9.30%
10-year avg
9.30%
Marpai, Inc.’s ROE is greater than Context Therapeutics Inc. (-58.75%), greater than Tivic Health Systems, Inc. (-201.30%), greater than PetVivo Holdings, Inc. (-1223.26%), greater than DatChat, Inc. (-72.63%), greater than Cyngn Inc. (-258.30%),
Company | ROE | Market cap |
---|---|---|
-58.75% | $104.25M | |
-201.30% | $2.05M | |
-1223.26% | $10.85M | |
-72.63% | $6.28M | |
-258.30% | $12.36M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Marpai, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Marpai, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Marpai, Inc.'s ROE?
How is the ROE calculated for Marpai, Inc. (MRAI)?
What is the highest ROE for Marpai, Inc. (MRAI)?
What is the 3-year average ROE for Marpai, Inc. (MRAI)?
What is the 5-year average ROE for Marpai, Inc. (MRAI)?
How does the current ROE for Marpai, Inc. (MRAI) compare to its historical average?